{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:55:13Z","timestamp":1761630913558,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejso.2020.05.029","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T21:07:11Z","timestamp":1592946431000},"page":"2276-2282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6898","authenticated-orcid":false,"given":"Aditi","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1233-5003","authenticated-orcid":false,"given":"Witold","family":"Gertych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Kammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loma","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakina","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Devouassoux-Shisheboran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-4974","authenticated-orcid":false,"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ejso.2020.05.029_bib1","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl","key":"10.1016\/j.ejso.2020.05.029_bib2","article-title":"Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20","volume":"38","author":"Du Bois","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.ejso.2020.05.029_bib3","article-title":"A\u00a0randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1\/SGOG-OV2","volume":"38","author":"Zang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.05.029_bib4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000007","article-title":"Ovarian cancer: sites of recurrence","volume":"23","author":"Amate","year":"2013","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.ejso.2020.05.029_bib5","series-title":"Management of peritoneal metastases- cytoreductive surgery, HIPEC and beyond","article-title":"Surgical management of recurrent epithelial ovarian cancer","author":"Bhatt","year":"2018"},{"key":"10.1016\/j.ejso.2020.05.029_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian cancer","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.05.029_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ijgc-00009577-200307000-00004","article-title":"Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: a retrospective case-control study","volume":"13","author":"Zang","year":"2003","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.ejso.2020.05.029_bib8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00268-007-9146-8","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients","volume":"31","author":"Cotte","year":"2007","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.ejso.2020.05.029_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/bjc.2011.328","article-title":"Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort","volume":"105","author":"Zang","year":"2011","journal-title":"Br J Canc"},{"key":"10.1016\/j.ejso.2020.05.029_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.05.029_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2009.11.022","article-title":"The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum","volume":"116","author":"Zivanovic","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2020.05.029_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13193-019-00875-z","article-title":"Impact of radicality versus timing of surgery in patients with advanced ovarian cancer (stage III C) undergoing CRS and HIPEC-a retrospective study by INDEPSO","volume":"10","author":"Bhatt","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.05.029_bib13","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.2174\/138161212802002616","article-title":"Survival benefit of adding hyperthermic IntraPEritoneal chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence","volume":"18","author":"Mulier","year":"2012","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.ejso.2020.05.029_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Canc Treat Res"},{"issue":"12","key":"10.1016\/j.ejso.2020.05.029_bib15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ejso.2019.07.019","article-title":"Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential- a prospective multi-centric study","volume":"45","author":"Bhatt","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.05.029_bib16","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-020-08234-x","article-title":"The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2020.05.029_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","article-title":"A\u00a0new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy stage evaluation (PROMISE) application","volume":"42","author":"Villeneuve","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2020.05.029_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejso.2019.11.495","article-title":"Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?","volume":"46","author":"Bhatt","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2020.05.029_bib19","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2006.03.025","article-title":"Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations","volume":"42","author":"Ferrandina","year":"2006","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.05.029_bib20","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the arbeitsgemeinschaft gynaekologische onkologie (AGO) DESKTOP OVAR Trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.05.029_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.ejso.2020.05.029_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.05.029_bib23","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2020.05.029_bib24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-016-5686-1","article-title":"Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases","volume":"24","author":"Di Giorgio","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.05.029_bib25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","article-title":"Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial","volume":"376","author":"Rustin","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2020.05.029_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2010.01.014","article-title":"Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?","volume":"117","author":"Tanner","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2020.05.029_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2018.05.020","article-title":"Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance","volume":"150","author":"Lindemann","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2020.05.029_bib28","first-page":"4997","article-title":"Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy for first relapse of ovarian cancer","volume":"35","author":"Classe","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2020.05.029_bib29","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.3802\/jgo.2018.29.e12","article-title":"Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study","volume":"29","author":"Ayhan","year":"2018","journal-title":"J\u00a0Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.05.029_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ygyno.2011.09.011","article-title":"Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer","volume":"124","author":"Tanner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.05.029_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2008.12.008","article-title":"Surveillance of patients after initial treatment of ovarian cancer","volume":"71","author":"Gadducci","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2020.05.029_bib32","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1245\/s10434-020-08208-z","article-title":"Extent of peritoneal resection for peritoneal metastases: looking beyond a complete cytoreduction","volume":"27","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320305497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320305497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:35:44Z","timestamp":1760060144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320305497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0748798320305497"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.05.029","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extent and distribution of peritoneal disease in patients undergoing cytoreductive surgery for first platinum sensitive recurrence in ovarian cancer and its potential therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}